Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy

• R. Yang ^[1] ; H. Dong ^[2] ; S. Jia ^[3] ; Z. Yang ^[2]
  1. [1] Department of Gastroenterology, The Second Hospital of Jilin University, Changchun 130000, China
  2. [2] Department of Gastrointestinal Surgery, The Second Hospital of Jilin University, Changchun 130000, China
  3. [3] Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin University, Changchun 130000, China

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 7, 2022, págs. 1219-1230
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Cancer is one of the leading causes of death, with a heavy socio-economical burden for countries. Despite the great advances that have been made in the treatment of cancer, chemotherapy is still the most common method of treatment. However, many side effects, including hepatotoxicity, renal toxicity, and cardiotoxicity, limit the efficacy of conventional chemotherapy.

    Over recent years, natural products have attracted attention as therapeutic agents against various diseases, such as cancer.

    Resveratrol (RES), a natural polyphenol occurring in grapes, nuts, wine, and berries, exhibited potential for preventing and treating various cancer types. RES also ameliorates chemotherapy-induced detrimental effects. Furthermore, RES could modulate apoptosis and autophagy as the main forms of cancer cell deaths by targeting various signaling pathways and up/ downregulation of apoptotic and autophagic genes. This review will summarize the anti-cancer effects of RES and focus on the fundamental mechanisms and targets for modulating apoptosis and autophagy by RES